King Charles III has been “deeply touched” by the response to his update on his cancer treatment, Buckingham Palace said Saturday, adding that the monarch is pleased to have highlighted the value of screening programs for the disease. Medics and health charities have praised the king for his openness, saying his statement on Friday had already prompted people to seek information about cancer. In a strikingly personal video statement, the British monarch acknowledged that a cancer diagnosis can

In the present progressively advanced world, keeping up with proficient handshakes can challenge. In any case, whether you're organizing on the web or face to face, the

These reality TV fans dropped thousands on BravoCon 2025. Take a peek at their receipts.

() -Infertility is an overlooked public health challenge and affordable treatment should be available within national health systems, the ​World Health Organization said on Friday in its first guideline on ‌the topic. Infertility is estimated to affect more than 1 in 6 people of reproductive age at some ‌point in their lives, the WHO said.

When you think of Italian sports cars, your mind probably conjures up images of exotic shapes, symphony-like engine notes, and colors that make traffic lights jealous. But beyond the passion and artistry that Italy pours ... Read more

Arranging a fair settlement after an auto collision is a significant stage during the time spent looking for pay for the

Picking the ideal cake for your extraordinary event can be a magnificent yet testing task. With a plenty of flavors,

Kennedy is one of about 50,000 Americans who have spasmodic dysphonia.

Nearly 300 Gazans needing medical care left Gaza via Israel and Jordan for treatment abroad after vetting and coordination with global partners. Hundreds of Gazans who require medical treatment exited the Gaza Strip via the Kerem Shalom Crossing on Monday, the Defense Ministry's Coordinator of Government Activities in the Territories (COGAT) said.

The viral holiday obsession sparked pricey resale listings and copycat alternatives.

Dec 19 () - BioMarin Pharmaceutical said on Friday it would acquire Amicus Therapeutics for about $4.8 billion, expanding ​its presence in rare metabolic diseases.

In a response to the High Court, Defense Minister Katz accused Army Radio workers of presenting false claims amid legal challenges to the station’s closure. Defense Minister Israel Katz sharply criticized the Army Radio workers' union in his response to the High Court of Justice on Monday, accusing the organization of attempting to mislead the court through what he described as false affidavits.

Picking the ideal sets of excellent remote headphones is an essential choice for any sound fan. With the market overwhelmed

NEW YORK, Dec 24 (Reuters) - Packaged food makers and fast-food restaurants may be forced to overhaul more of their products next year as newly approved, appetite-suppressing GLP-1 pills become available in January, analysts say. More Americans are expected to try the ​drugs as a pill rather than as a shot because the medication will be cheaper and many patients are hesitant to inject themselves.

Voyager 1, NASA’s deep-space probe, could soon become the first spacecraft to reach a historic milestone. In November 2026, the probe will be one light-day from Earth.

By Kamal Choudhury and Christy Santhosh (Reuters) -The U. Food and Drug Administration on Thursday approved Kura Oncology and Japanese ​partner Kyowa Kirin's once-daily pill, Komzifti, to treat a ‌rare form of blood cancer that has returned or stopped responding to treatment.

Kayaking offers an exhilarating and vivid method for investigating streams, furnishing close experiences with nature and the peacefulness of skimming

NEW YORK, Dec 31 (Reuters) - Drugmakers plan to raise U. prices on at least 350 branded medications including vaccines against COVID, RSV and shingles and blockbuster cancer treatment Ibrance, even as the Trump administration pressures them for cuts, according to data provided exclusively ​by healthcare research firm 3 Axis Advisors.

BERLIN () -German pharma company Bayer reported positive study ​results for its anticoagulant asundexian on Sunday,‌ two years after a research setback for the ‌promising blood thinner candidate. In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared ⁠with a placebo,‌ Bayer said.

'tis the season to stream all your favorite holiday movies!